FRI0103 One-Year Follow-Up of a Nationwide Cohort of Patients With Inflammatory Arthritis, Who Switched From Originator to Biosimilar Etanercept, Focusing on Patients Who Switched Back to Originator. An Observational Danbio Study
doi 10.1136/annrheumdis-2018-eular.2296
Full Text
Open PDFAbstract
Available in full text
Date
June 1, 2018
Authors
Publisher
BMJ Publishing Group Ltd and European League Against Rheumatism